This inventor holds 1 USPTO granted patent. Top assignee: Casma Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Andrew Thomas Maynard: Innovator in Pharmaceutical Compounds
Introduction
Andrew Thomas Maynard is a notable inventor based in Winchester, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on TRPML modulators. His research focuses on developing compounds and compositions that have potential therapeutic applications.
Latest Patents
Andrew Maynard holds a patent for TRPML modulators. The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Andrew is currently associated with Casma Therapeutics, Inc., where he continues to push the boundaries of pharmaceutical research. His work at Casma Therapeutics emphasizes the importance of innovation in developing new treatments for various medical conditions.
Collaborations
Andrew collaborates with talented individuals in his field, including Jorge Garcia Fortanet and Jeffrey Owen Saunders. These partnerships enhance the research environment and foster the development of groundbreaking solutions in pharmaceuticals.
Conclusion
Andrew Thomas Maynard is a dedicated inventor whose work in TRPML modulators exemplifies the impact of innovation in the pharmaceutical industry. His contributions are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile